TSX VENTURE COMPANIES
ACASTI PHARMA INC. ("ACST")
BULLETIN TYPE: Delist
BULLETIN DATE: March 13, 2023
TSX Venture Tier 2 Company
Further to the Company's news release dated March 13, 2023, the common shares of Acasti Pharma Inc. (the "Company") will be delisted from TSX Venture Exchange effective at the close of business on Monday, March 27, 2023.
The delisting of the common shares of the Company is completed at the request of the Company. The common shares of the Company trade on the NASDAQ under the symbol "ACST".
For more information, please consult the Company's news release dated March 13, 2023.
ACASTI PHARMA INC. (" ACST ")
TYPE DE BULLETIN : Retrait de la cote
DATE DU BULLETIN : Le 13 mars 2023
Societe du groupe 2 de TSX Croissance
Suite au communique de presse de la societe date du 13 mars 2023, les actions ordinaires d'Acasti Pharma inc. (la " societe ") seront retirees de la cote de la Bourse de croissance TSX a la fermeture des affaires le lundi 27 mars 2023.
Le retrait de la cote des actions ordinaires de la societe est complete a la demande de la societe. Les actions ordinaires de la societe transigent au NASDAQ sous le symbole " ACST ".
Pour plus de renseignements, veuillez consulter le communique de presse de la societe date du 13 mars 2023.
________________________________________
|
|
